Always verify pricing and state availability on the provider's website before signing up.How our reviews work →
TMates vs Zealthy
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
6.3
TMates
Best for nationwide compounded GLP-1 availability including Puerto Rico★★★☆☆3.2
Starting at $199/mo
CompoundedSemaglutideTirzepatideAll 50 States + PR
Visit TMates →4.8
Zealthy
Best for not currently recommended — listed for transparency and reader awareness only★★☆☆☆2.4
Starting at $286/mo
CompoundedSemaglutideTirzepatide
Visit Zealthy →Side-by-Side Comparison
| Feature | TMates | Zealthy |
|---|---|---|
| Overall Score | ✓6.3/10 | 4.8/10 |
| Starting Price | ✓$199/mo | $286/mo |
| Editorial Rating | ✓3.2 ★ /5 | 2.4 ★ /5 |
| Features | ✓4 features | 3 features |
| States Available | 0 | ✓34 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | ✓None | 2 warnings |
Pros & Cons
TMates
Pros
- ✓All-inclusive monthly pricing covers medication, consultations, nutrition coaching, and 24/7 support with no separate membership fee
- ✓Available in all 50 US states plus Puerto Rico and other US territories
- ✓Both compounded semaglutide and tirzepatide offered
- ✓Fast stated turnaround (intake to medication delivery in 2–3 days)
Cons
- ✗No disclosed third-party accreditations (no verified LegitScript, PCAB, ACHC, or NABP) — weaker pharmacy-oversight signal than competitors
- ✗BBB rating B+ (not accredited) with 8 complaints filed, most involving billing and cancellation friction
- ✗Trustpilot reviews show partial-refund and contact-difficulty reports, and some customer posts allege reviews have been removed
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Pharmacy partners not publicly named — TMates explicitly disclaims both medical practice and pharmacy dispensing responsibility, routing both to independent third parties
- ✗Also sells Schedule III testosterone products and other wellness SKUs alongside GLP-1s — worth knowing about for readers who want a GLP-1-focused provider
Zealthy
Pros
- ✓34 states served — meaningful nationwide footprint
- ✓Asynchronous model removes friction for patients comfortable without a synchronous video visit
- ✓Independent licensed prescribers retain full clinical authority
Cons
- ✗TWO FDA warning letters for false/misleading marketing of compounded GLP-1s (Feb 2026 letter 717987 verified at fda.gov; September 2025 letter from secondary sources)
- ✗Active Novo Nordisk false-advertising lawsuit: Novo Nordisk A/S et al v. Zealthy Inc., case 1:25-cv-06391 (S.D.N.Y., filed 2025-08-04), alleging trademark infringement and marketing of compounded products as 'FDA-approved alternatives'
- ✗Active DOJ/FTC enforcement: United States v. Cerebral, Inc. et al, case 1:24-cv-21376 (S.D. Fla., amended complaint adding Zealthy Inc., Gronk Inc., founder Kyle Robertson, and others), alleging ROSCA violations (failure to disclose subscription terms, no informed consent for billing, locked cancellation), and unauthorized health-data sharing for targeted advertising
- ✗Founder pattern of conduct: Kyle Robertson previously founded Cerebral, which settled with the FTC in June 2024 ($5M consumer redress + $10M civil penalty suspended to $2M) for similar deceptive practices. Robertson then founded Zealthy and is alleged to have continued the same conduct
- ✗Company recently renamed FitRX/Zealthy to Gronk Inc. — rebrand pattern is itself a concerning signal in the context of active enforcement
- ✗Continued marketing of compounded semaglutide after FDA removed it from the shortage list on 2025-02-21 (post-shortage compounding without legal authorization)
- ✗Adds a $135/month membership fee on top of medication cost — total cash price is $286-$351/month
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
Our Verdict
Winner: TMatesScore: 6.3/10
TMates edges out Zealthy with a higher overall score of 6.3/10 and is particularly strong for nationwide compounded GLP-1 availability including Puerto Rico. Zealthy remains a solid alternative, especially if you're looking for not currently recommended — listed for transparency and reader awareness only.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.